Coldstream Capital Management Inc Vanda Pharmaceuticals Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 2,650 shares of VNDA stock, worth $12,163. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,650Holding current value
$12,163% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VNDA
# of Institutions
156Shares Held
43.4MCall Options Held
72.4KPut Options Held
197K-
Black Rock Inc. New York, NY8.14MShares$37.4 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.57MShares$16.4 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.5MShares$16 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.54MShares$11.7 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$10.8 Million0.85% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $260M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...